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ABSTRACT
Introduction: Down syndrome (DS) is caused by trisomy of human chromosome 21 (HSA21). Motor dysfunction due 
to hypotonia has limited labour productivity and have significant effects on socio-economic status in DS individuals. 
Ts1Cje, a mouse model of DS that exhibits muscle weakness was employed, to investigate the expression profile of 
selected trisomic and disomic genes involved in skeletal muscle structure and function. Methods: Quadriceps and 
triceps were harvested from the Ts1Cje (C57BL/6) postnatal day 60-70 mice and corresponding wild-type littermates. 
Total RNA extracted from these tissues was subjected for quantitative expression profiling of three trisomic genes 
(Itsn1, Synj1 and Rcan1) involved in neurotransmission and six disomic genes (Lamc1, Leprel1, Myl6b, Msn, Pgm5 
and Tmod1) essential for maintenance of muscle structure and function. Real-time quantitative PCR method was 
used for the profiling. Results: Differential gene expression in DS is reflected by 1.5-fold or more increase in the level 
of expression as predicted by the gene dosage imbalance hypothesis. The analysis showed no significant changes in 
the expression level of trisomic genes (Itsn1, Synj1 and Rcan1). On contrary, disomic genes, Leprel1 and Pgm5, were 
upregulated for more than 1.5-fold in DS quadriceps whereas Lamc1, Myl6b and Pgm5 were upregulated for more 
than 1.5 fold in DS triceps as compared to the wild-type group. Conclusions: Our findings suggest that the dysregu-
lation of Lamc1, Leprel1, Myl6b and Pgm5 genes is associated to muscle weakness seen in Ts1Cje and may play a 
role in molecular pathogenesis of muscle weakness in DS.
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INTRODUCTION
Down syndrome (DS) is a chromosomal disorder caused 
by trisomy of human chromosome 21 (HSA21) (1). The 
prevalence of the disorder is 1 in 800 to 1,000 live 
births across different ethnic groups (2) and 1 in 959 
live births in Malaysia (3). DS is characterised with 
over 70 phenotypes including intellectual disability, 
cardiac defect (1, 4-5) and hypotonia (weak muscle 
tone) (6,7). DS individuals suffer with limitation in 
labour productivity and economic self-dependency, 
which eventually affect the socio-economic statue of 
such individual and the community at large. Effort to 
study the pathogenesis of hypotonia in DS individuals is 
limited due to the lack of comprehensive investigations 
at molecular and cellular levels.
Different mouse models for DS have been produced 
genetically to provide a better understanding on various 
phenotypes associated with the disorder (8,9). The 
HSA21 shared a conserved synteny with orthologous 
regions of three mouse chromosomes, MMU10, 
MMU16 and MMU17 (10). Ts1Cje, a DS mouse model 
that carries a shorter region of MMU16 with ~85 genes 
(Sod1-Znf295) synteny to those located on HSA21 (8) 
was employed in the present study. Triplication of these 
genes have been associated with features seen in DS 
individuals (11). 
Various hypotheses have been proposed to correlate 
the genotype and phenotype seen in DS individuals. 
It is believed that either the entire HSA21 is causing a 
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global genomic imbalance or specific regions in HSA21 
are causing multitude of DS traits via their respective 
genotype-phenotypes contribution (12). Two most 
acceptable hypotheses are (i) gene dosage imbalance 
hypothesis, and (ii) amplified developmental instability 
hypothesis. The gene dosage imbalance hypothesis 
suggests that there is an average of 50% higher 
expression of HSA21 genes in DS samples as compared 
to the euploid samples (13). This hypothesis is supported 
by previous transcriptomic studies on the brain and 
neural progenitor cells isolated from Ts1Cje (14-15).  On 
the other hand, the amplified developmental instability 
hypothesis postulated that the dosage imbalance of 
HSA21 genes leads to a general disruption of genomic 
regulation and expression and further upsets the cellular 
homeostasis (16). 
Ts1Cje mice have profound motor dysfunction with 
weak muscle strength, poor balance and impaired motor 
coordination compared with their control littermates 
(17). Hence, we further dissected the molecular 
mechanisms that underlie muscle weakness in DS. In this 
study, three trisomic genes; namely, intersectin1 (Itsn1), 
synaptojanin1 (Synj1) and regulator of calcineurin 
(Rcan1) which are involved in neuromuscular 
transmission were selected for evaluation in the skeletal 
muscles of Ts1Cje mouse model. These genes are located 
on the Down syndrome critical region (DSCR) of HSA21 
(1) and upregulation of these genes have been shown 
to cause motor defects by affecting the neuromuscular 
junction activities and synaptic morphology leading 
to motor impairment in Drosophila (18). To date, the 
expression profile of these genes has not been reported 
in Ts1Cje skeletal muscles. 
Skeletal muscle is a key player in motor movement 
and effective motor performance, which depends 
on its structural and functional integrity. Six disomic 
genes namely, laminin gamma-1 (Lamc1), leprecan-
like protein-1(Leprel1), myosin light chain 6B 
(Myl6b), Moesin (Msn), tropomodulin-1(Tmod1) and 
phosphoglucomutase-5 (Pgm5) are known to play 
essential roles in the maintenance of skeletal muscle 
structure and function. To the best of our knowledge, the 
expression profile of these genes has yet to be reported 
in skeletal muscles of Ts1Cje mouse model and therefore 
were selected for the study. We hypothesised that global 
genomic imbalance due to trisomy 21 may dysregulate 
the expression of genes involved in the maintenance of 
structural function of the skeletal muscles.
METHODS
Ethical approval, animal breeding, genotyping, and 
husbandry
Two groups of mice, the Ts1Cje (n = 9) and wild-type 
(WT) (C57BL/6) (n = 8) at postnatal day 60-70 were used 
in the study. The Ts1Cje males were mated with the 
WT C57BL/6 females. Polymerase chain reaction (PCR) 
technique was used to genotype genomic DNA obtained 
from mouse tail biopsy. The amplification of the Grik1 
gene alone or both Grik1 and Neo genes indicate WT 
and Ts1Cje genotypes, respectively (8). Mice were kept 
in the individually ventilated cages at Genetics and 
Regenerative Medicine Research Centre (GRMRC), 
Faculty of Medicine and Health Sciences, Universiti 
Putra Malaysia (UPM). All mice were housed under 
controlled temperatures with a 12:12 hour light:dark 
cycle. The mice were given unlimited access to standard 
animal feed (Altromin 1324, Germany) and clean water 
ad libitum.  This study was approved by the Institutional 
Animal Care and Use Committee (IACUC), UPM 
(Reference number: UPM/IACUC/AUP-R030/2015). 
Animals handling was performed in accordance with 
IACUC guidelines.
Sample collection 
The mice were deeply anaesthetised with inhalation of 
4% (v/v) isoflurane to eliminate perception of pain prior 
to cervical dislocation. The mice were disinfected with 
70% ethanol, pinned on dissecting board and the entire 
skin of the limbs was incised. Quadriceps and triceps 
which are the largest skeletal muscles of hindlimb 
and forelimb, respectively, were exposed, excised and 
collected. Each muscle tissue was rinsed with chilled 
1X phosphate buffered saline (PBS) followed by snapped 
frozen on dry ice and stored at -80°C for RNA isolation.
RNA isolation and cDNA synthesis
Genomic-free total RNA from the skeletal muscle 
was extracted using the RNeasy Lipid Tissue Mini Kit 
(Qiagen) according to manufacturer’s protocol. The 
concentration, purity and integrity of the extracted 
RNA were assessed by using the NanoVueTM Plus 
Spectrophotometer (GE HealthCare), agarose gel 
electrophoresis and Agilent 2100 Bioanalyzer (Agilent). 
The RNA sample with A260/280 ratio values ranging 
from 1.9-2.1 were considered of high purity. RNA 
Integrity Number (RIN) above 5 was defined as good 
quality total RNA and RIN above 8 as perfect quality 
total RNA (scale of 1 to 10, 1 = lowest and 10 = highest) 
suitable for RT-qPCR analysis (19). First strand of cDNA 
was synthesized from good quality total RNA using the 
SuperScript™ III Reverse Transcriptase Kit (Invitrogen), 
according to manufacturer’s protocol, under an RNAse-
free environment. 
Primer Design and RT-qPCR 
Primers were designed using ProbeFinder version 2.45 
at the Universal ProbeLibrary (UPL) Assay Design Centre 
(Roche Applied Science; www.lifescience.roche.com). 
Relevant UPL probe was selected for each primer. For 
the selection of the primers, the following parameters 
were considered; length between 19-23bp, GC % 
between 45-58, Tm between 55-60 °C and amplicon 
size between 69-143 bp. All primers were synthesised 
by 1st BASE (Malaysia) except for Itsn, Syjn and Rcan1 
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(Bioneer, Korea). All primers used are tabulated in Table 
I. A total volume of 10μl of final reaction was prepared 
for the real-time quantitative PCR (RT-qPCR) containing 
1X LightCycler® 480 (LC480) Probe Master Mix (Roche 
Diagnostics, USA), 0.25μM each of forward and reverse 
primers, 0.1μM of an appropriate UPL probe (Roche 
Diagnostics, USA), PCR grade water (Roche Diagnostics, 
USA) and finally 1μl of diluted (0.2X) synthesised cDNA. 
The RT-qPCR was performed using LightCycler® 480 
Real Time PCR System instrument (Roche Diagnostics, 
USA). Briefly, the RT-qPCR consists of three different 
steps; pre-incubation, amplification and cooling step. 
The samples were pre-incubated (denaturation) at 95°C 
for 10 minutes followed by amplification for 45 cycles 
at 95°C for 15 seconds, 60°C for 30 seconds and 72°C 
for 1 second and a final step (cooling) was at 40°C for 
30 seconds.
For each primer set used in the RT-qPCR, a 4-5 data-point 
standard curve was constructed using serially diluted 
(0.2X) pooled cDNA samples. The standard curve was 
used to determine the efficiency and reproducibility 
of each RT-qPCR assay. Three housekeeping genes; 
phosphoglycerate kinase 1 (Pgk1), proteasome subunit 
beta type 2 (Psmb2) and hydroxymethylbilane synthase 
(Hmbs) were used for data normalisation. An assay was 
considered successful when the PCR efficiency was 
between 85-110% with r2 > 0.985 and a minimum of 
two successful assays for housekeeping genes in each 
experimental batch. Relative quantification by standard 
curve method was employed to compare the level of 
expression of selected genes (20-21). The data obtained 
was analysed using GraphPad Prism v6 (GraphPad 
Software) statistical programme and the results are 
expressed as mean ± SEM.  Two tailed unpaired t-test 
was used to compare the log
2
 normalised expression of 
each gene between the Ts1Cje and the WT mice. Genes 
with expression fold change value of >1.5 or <-1.5 
between the two groups are considered differentially 
expressed according to the gene dosage imbalance 
hypothesis. The differences are considered statistically 
significant when p-value<0.05. 
 
RESULTS
RNA quality and integrity 
All RNA samples were having A260/280 nm absorbance 
ratios between 1.9 and 2.1 indicating a high purity 
extracts. In addition, agarose gel electrophoresis of 
the RNA samples indicated the presence of both 28S 
and 18S bands representing good RNA integrity (Fig. 
1A). Agilent 2100 Bioanalyzer analyses confirmed all 
extracted RNA samples were of high integrity with RIN 
between 7.8-9.1 (Fig. 1B). 
Table I: List of all the primers used in this study
Name Pr. L Tm %GC Sequence (5’→3’) Size (nt) UPL Probe ID
Lamc1
F 21 59 52 gaggtgaatggtatgctgagg
130 #16R 19 59 58 cattgagctcagcctcctg
Leprel1
F 22 60 50 ttacactggaccctctttaccg
69 #96R 22 60 45 gatccaagatggcaatcacttc
Msn
F 20 59 55 ggaagagctgatggagaagc
109 #68R 20 59 50 cttccgttcctgctcaagtt
Myl6b
F 20 60 50 caacggctgcatcaactatg
103 #19R 20 55 55 cttgcctctcaagcggatac
Pgm5
F 19 60 58 tcacgaccaggaaccacag
138 #99
R 20 59 50 atctctcggagtgctctgct
Tmod1
F 21 59 52 cgtggagtccaacttcatctc
120 #33R 20 60 45 actttgttgcccaaaggttg
Itsn1
F 20 59 50 accagttctcgcctgatgat
139 #18R 19 60 58 aggcggaccacaatctctc
Synj1
F 19 60 53 ctcctgacagccaaagcaa
143 #18R 20 59 55 ggcttcagtggttctggaag
Rcan1
F 20 59 50 cccgacaaacagttcctcat
70 #52R 23 60 48 gcatgcagttcatacttctctcc
Pgk1
F 18 60 61 tacctgctggctggatgg
65 #108R 20 60 50 cacagcctcggcatatttct
Psmb2
F 20 59 55 gagggcagtggagcttctta
71 #25R 20 60 50 aggtgggcagattcaagatg
Hmbs
F 20 59 45 aaagttccccaacctggaat
96 #35R 20 60 50 ccaggacaatggcactgaat
Pr. = Primer; F=Forward; R=Reversed; L= Length (nt); Tm= Melting temperature (oC)
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Figure 1: Integrity and quality of total RNA and DNA genotyping. (A) Gel electrophoresis of representative good quality total RNA samples show 
intact 28S rRNA bands that are approximately twice as intense as the 18S rRNA bands. (B) Representative electropherogram generated by Agilent 
2100 Bioanalyser shows the presence of distinctive 18S and 28S peaks indicating high RIN score of 8.6. (C) Gel electrophoresis of PCR amplicons 
from DNA genotyping analysis. Ts1Cje mice is represented by two bands, Grik1 (333 bp) and Neo (150 bp) (lanes A, C and D) while only Grik1 
was amplified in wildtype sample (lane B). There is no PCR amplification in lane E which served as the negative control (NTC) 
Genotyping
The PCR products were subjected to gel electrophoresis 
for genotyping purpose. The Grik1 gene lies in 
chromosome 16 and served as internal control. PCR 
amplified the Grik1 gene in WT mice only, while both 
Grik1 and Neo genes were amplified in the Ts1Cje 
mouse (Fig. 1C). 
Gene expression profile
The expression profiles of three trisomic genes (Itsn1, 
Synj1 and Rcan1) and six disomic genes (Lamc1, Leprel1, 
Myl6b, Msn, Pgm5 and Tmod1) were performed. For 
comparison, a fold change (FC) of ± 1.5 was considered 
differentially expressed and reported as upregulation or 
downregulation, respectively. RT-qPCR result showed 
no differences in the expression of Itsn1, Synj1, and 
Rcan1 between the Ts1Cje and WT groups for both 
quadriceps and triceps (Fig. 2A-C and Table II). The 
FC analysis of all the trisomic genes in both quadriceps 
and triceps showed very small differences in the level of 
expression between the Ts1Cje and the WT mice (Table 
2) with FC values were relatively close to 1. 
No significant differences were observed in the 
expression level of all selected disomic genes between 
Ts1Cje and WT groups (Table II, Fig. 2D-I). Lamc1, 
Myl6b and Pgm5 expression were upregulated for 
approximately 1.7-, 1.6- and 2.2-fold, respectively, in 
triceps of Ts1Cje mice as compared with the WT group 
(Fig. 2D, F & H, Table II). There was more than 1.5-
fold upregulation in the Leprel1 and Pgm5 expression 
level in the quadriceps of the Ts1Cje mice as compared 
to the WT with approximately 1.70- and 3.50-fold, 
respectively (Fig.2E & H, Table II).  
DISCUSSION 
For several years, efforts have been made by scientists 
to understand the relationship between the increased 
gene dosage and phenotypic appearances such as 
hypotonia in DS individuals. However, there is no 
clear understanding of how trisomy 21 causes muscle 
weakness in DS individuals. It is known that, motor 
performance is a collective function of the nervous and 
skeletal systems. A defective muscular system affects the 
motor function of an individual even in the presence of 
functional nervous system and vice versa. Thus, in an 
attempt toward understanding the molecular basis of the 
muscle weakness in DS, the expression profile of nine 
protein coding genes in Ts1Cje skeletal muscles was 
evaluated. The genes of interest included three trisomic 
genes (Itsn1, Synj1 and Rcan1) that are involved in 
neuromuscular transmission and other six disomic 
genes (Lamc1, Leprel1, Myl6b, Msn, Tmod1, and Pgm5) 
that are known to play essential roles in structural and 
functional stability of skeletal muscle. 
It is believed that, the presence of an extra copy of 
chromosome 21 in DS individuals would result in 50% 
increment in the expression level of all the trisomic 
genes compared to the disomic genes. Rcan1, Itsn1 and 
Synj1 are trisomic genes located within the triplicated 
region of Mmu16 of the Ts1Cje mice. Surprisingly, their 
expression level in the quadriceps and triceps of Ts1Cje 
mice was nearly similar to that of the WT mice. Using 
microarray technique and FC analysis, the expression 
level of Rcan1 and Itsn1 but not Synj1 was significantly 
greater than 1.5 in the soleus of another DS mouse 
model, Ts65Dn (22). Similarly, another study revealed 
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Figure 2: Relative quantitation of gene expression by standard curve method. The bar chart represents the Log2 normalised ex-
pression (against Pgk1, Psmb2 and Hmbs housekeeping genes) of selected trisomic and disomic genes for Ts1Cje (n=9) and WT 
groups (n=8). Values are presented as mean±SEM. Relative gene expression of quadriceps and triceps of Ts1Cje is expressed as 
fold change (FC) against the WT group.  
Table II: Expression profile of the selected genes
Gene 
group
Gene Name & 
symbol
Quadriceps Triceps
Ts1Cje 
(mean ± SEM )
WT
(mean ± SEM )
Fold 
change
P value Ts1Cje 
(mean ± SEM )
WT
(mean ± SEM )
Fold 
change
P value 
Tr
is
om
ic
 g
en
es
Intersectin 
(Itsn1)
1.337 
± 0.013
1.340
± 0.012
0.9976
0.848
1.311
± 0.016
1.336
± 0.024
0.9832 0.407
Synaptojanin 
(Synj1)
1.369
± 0.007
1.387
± 0.012
0.9875 0.199
1.365
± 0.012
1.373
± 0.019
0.9943 0.721
Regulator of 
calcineurin 
(Rcan1)
1.049
± 0.014
1.077
± 0.013
0.9809 0.162
1.100
± 0.041
1.080
± 0.016
1.0142 0.652
D
is
om
ic
 g
en
es
Laminin gam-
ma 1 (Lamc1)
2.765
± 0.322
2.650
± 0.459
1.3134 0.837
2.990
± 0.371
2.233
± 0.417
1.6889 * 0.194
Leprecan-like 
1 (Leprel1) 
3.169
± 0.314
2.405
± 0.301
1.6990 * 0.101
3.100
± 0.382
2.764
± 0.417
1.2630 0.559
Myosin light 
polypeptide 
6B (Myl6b)
4.715
± 0.300
4.444
± 0.329
1.2066 0.557
4.970
± 0.253
4.283
± 0.321
1.610 * 0.115
Moesin (Msn)
2.707
± 0.485
2.253
± 0.383
1.3690 0.482
2.991
± 0.358
2.721
± 0.380
1.2066 0.611
Phosphoglu-
comutase 5 
(Pgm5)
3.623 
± 0.811
1.814 
± 0.500
3.5016 * 0.086
4.140
±0.580
3.010
± 0.465
2.1886 * 0.156
Tropomodulin 
1 (Tmod1)
3.185
± 0.443
3.547
± 0.522
0.7778 0.602
3.610
± 0.515
3.391
± 0.459
1.164 0.757
* Indicates a fold change of ≥ 1.5 upregulated
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an upregulation of Itsn1 and Synj1 in an unspecified 
skeletal muscle in Ts65Dn mice using RT-qPCR (23). 
There are two major differences that distinguish the 
current study from the previously reported studies 
including the choice of DS mouse model and the type of 
the muscle used. Most of the studies that characterised 
gene expression profiles in the skeletal muscle of DS 
mouse and their relation to muscle functionality was 
performed in the Ts65Dn model. Both Ts1Cje and 
Ts65Dn mouse models shared a segment of triplicated 
region of Mmu16 but it is important to take into 
consideration that the genetic make-up of these two 
models for DS differs (24,25). Ts65Dn model has partial 
trisomy of Mmu16 with approximately 132 known 
trisomic genes (App-Znf295) synteny to Hsa21 (26). 
The major setback of this model includes 19 trisomic 
genes which are not syntenic to HSA21 (15) and these 
differences in the genetic materials have significantly 
influenced the phenotypic features observed in these 
two models for DS and perhaps affecting on the level 
at which certain genes are expressed. In general, there 
are limited studies that characterise gene expression 
profile in Ts1Cje mice skeletal muscle especially in 
quadriceps and triceps suggesting the current findings 
as novel and the differentially expressed genes may 
serve as candidates to further understand the underlying 
mechanism of muscle weakness. 
Six disomic genes namely (Lamc1, Leprel1, Myl6b, Msn, 
Tmod1 and Pgm5) which are known to play essential 
roles in the skeletal muscle structure and function were 
selected in this study. Lamc1 is a major non-collagenous 
component of basement membrane and is essential for 
normal cardiac and skeletal muscle formation during 
embryonic development (27). Lamc1 null mouse 
embryos failed to develop basement membrane leading 
to increased deposition of extracellular matrix between 
adjacent cells, thus, interfering with electrical signal 
propagation (28).  Leprel1 is a gene of the Leprecan 
family of proteoglycans that is highly expressed in most 
tissues including the sarcoplasm of skeletal muscle (29) 
and mutated Leprel1 resulted in abnormal collagen in 
the sclera (30). Myl6b is an ATPase cellular motor protein 
expressed in both smooth and skeletal muscle (31) and 
its mutation leads to decreased force of contraction and 
velocity of shortening in smooth muscles (32).  Msn, 
together with Ezrin and Radixin formed ERM protein 
family which are the membrane cytoskeleton proteins. 
ERM are essential in regulating structure and function 
of plasma membrane (33). Disruption in epithelial cells 
morphology was observed in cells lacking Msn (34). 
Tmod1 is essential for striated muscle development and 
function as capping protein (35). Tmod1-null embryos 
showed normal skeletal muscle development but with 
cardiac defects (36,37).  Pgm5 is a cytoskeletal protein 
which forms a part of the various cell-matrix adheres 
junctions in muscle cell. Lack of Pgm5 has resulted in 
failure in membrane attachment and myofibril assembly 
as well as significant reduction in myofibril number 
(38).  The present study shows that the expression of the 
disomic genes of interest in Ts1Cje mice differs from that 
of the WT mice. Fold change analysis revealed higher 
expression of three disomic genes (Lamc1, Leprel1 
and Pgm5) in Ts1Cje mice relative to WT mice in the 
selected skeletal muscles. The observation suggests 
that they may exert certain level of influences on the 
neurotransmission, structure and function of the skeletal 
muscle in Ts1Cje mice. 
There were limited studies on the skeletal muscle 
function of the mouse models for DS. To the best of 
our knowledge, this is the first study investigating the 
expression profiles of selected trisomic and disomic 
genes in the targeted muscle types of Ts1Cje mice. 
To further determine the causative genes for muscle 
weakness in Ts1Cje mouse model, global transcriptomic 
analysis of the genes in the skeletal muscles of the Ts1Cje 
is highly recommended, hence, provide a broader view 
of the molecular basis that may lead to muscle weakness 
as well as targets for future therapy.
CONCLUSIONS
In this study, Lamc1, Leprel1, Myl6b and Pgm5, which 
were implicated in structural and functional stability of 
the skeletal muscle have higher levels of expression in 
Ts1Cje skeletal muscle as compared to wild-type group. 
The data provide a rationale for further investigation of 
their biological significance particularly in the molecular 
pathogenesis of muscle weakness in DS individuals.
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